FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041285232> ?p ?o ?g. }

• W2041285232 endingPage "161" @default.
• W2041285232 startingPage "143" @default.
• W2041285232 abstract "Hypertension, as in adults, is a frequent complication found in children with chronic kidney disease (CKD). Indeed, hypertension has now become one of the most prevalent chronic diseases of childhood. The most recent data available (2003) indicate that at least 38% of children with CKD in the United States are receiving antihypertensive therapy. Only recently has it been shown in children that hypertension, traditionally considered a marker for disease severity in children, is additionally a significant and independent risk factor for accelerated deterioration of kidney function and progression of CKD and a significant risk factor for cardiovascular disease. The following review outlines the differences and similarities of childhood versus adult hypertension with respect to measurement, diagnosis, treatment, and consequence in CKD. The definition of hypertension changes continually as a child grows with or without CKD. Despite numerous guidelines, the diagnosis of childhood hypertension continues to be based on epidemiologic data rather than evidence. For children, the current definition includes 2 categories: high normal, which is blood pressure (BP) between the 90th and 95th percentile, and hypertensive, which is BP above the 95th percentile. The evaluation of all hypertensive children should include a complete assessment of end-organ damage, including eyes, cardiovascular system (including blood vessels), kidneys, and nervous system. For children with CKD and end-stage renal disease (ESRD), a high percentage have left ventricular hypertrophy (LVH). The finding of end-organ damage or comorbidity (CKD, diabetes) in any child is an absolute indication for immediate pharmacologic therapy, whereas the presence of hypertension above the 95th percentile in children without CKD warrants initial intervention such as life style modification. The guidelines for measurement of BP in children with CKD are similar to those in children without CKD and include casual BP measurement, self-measured BP, and ambulatory BP monitoring. The recommendation for BP measurement in children is, when permitted, by auscultative method with a well-calibrated mercury manometer. Most casual BP measurements are performed with an automated oscillometric device whose validation has not been confirmed in children with CKD. The ambulatory BP monitor (ABPM) has 2 advantages: it significantly correlates with the presence of end-organ damage, and it identifies abnormal BP patterns that are frequently present in CKD patients, such as hypertension during the sleep period. An abnormal ABPM pattern can also be predictive of the development of end-organ damage. Treatment of hypertension in children, with and without CKD, is based on 3 factors: degree of BP elevation, the presence of cardiovascular risk factors, and the presence of end-organ damage. Additionally, the initial antihypertensive agent may be selected on available and age-appropriate formulations (eg, suspension and dosage selection). A physician treating a hypertensive child with CKD faces multiple challenges. They include selecting the convenience of available automated devices and the ABPM versus traditional auscultatory techniques upon which all normative standards have been based. Current research initiatives propose to develop pharmacokinetic and pharmacodynamics properties of antihypertensive medications and to study the effect of early intervention on end-organ damage." @default.
• W2041285232 created "2016-06-24" @default.
• W2041285232 creator A5023828011 @default.
• W2041285232 creator A5057178145 @default.
• W2041285232 date "2004-04-01" @default.
• W2041285232 modified "2023-09-23" @default.
• W2041285232 title "Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease" @default.
• W2041285232 cites W1522833532 @default.
• W2041285232 cites W1964897621 @default.
• W2041285232 cites W1971608831 @default.
• W2041285232 cites W1973672723 @default.
• W2041285232 cites W1976750597 @default.
• W2041285232 cites W1978575803 @default.
• W2041285232 cites W1981171681 @default.
• W2041285232 cites W1981607707 @default.
• W2041285232 cites W1983189528 @default.
• W2041285232 cites W1986336227 @default.
• W2041285232 cites W1988973154 @default.
• W2041285232 cites W1993039788 @default.
• W2041285232 cites W1996011432 @default.
• W2041285232 cites W1996136335 @default.
• W2041285232 cites W1998350487 @default.
• W2041285232 cites W1999580826 @default.
• W2041285232 cites W1999648128 @default.
• W2041285232 cites W2004248853 @default.
• W2041285232 cites W2005026202 @default.
• W2041285232 cites W2006220937 @default.
• W2041285232 cites W2008036896 @default.
• W2041285232 cites W2010778514 @default.
• W2041285232 cites W2011086163 @default.
• W2041285232 cites W2012370654 @default.
• W2041285232 cites W2013908723 @default.
• W2041285232 cites W2018593159 @default.
• W2041285232 cites W2024543376 @default.
• W2041285232 cites W2024825620 @default.
• W2041285232 cites W2026767701 @default.
• W2041285232 cites W2027350418 @default.
• W2041285232 cites W2031618867 @default.
• W2041285232 cites W2034647476 @default.
• W2041285232 cites W2035340899 @default.
• W2041285232 cites W2038940766 @default.
• W2041285232 cites W2039127460 @default.
• W2041285232 cites W2041000173 @default.
• W2041285232 cites W2042855357 @default.
• W2041285232 cites W2044454891 @default.
• W2041285232 cites W2046049654 @default.
• W2041285232 cites W2049165844 @default.
• W2041285232 cites W2051685647 @default.
• W2041285232 cites W2053287639 @default.
• W2041285232 cites W2055258815 @default.
• W2041285232 cites W2061538656 @default.
• W2041285232 cites W2064296101 @default.
• W2041285232 cites W2064624316 @default.
• W2041285232 cites W2078064069 @default.
• W2041285232 cites W2079403112 @default.
• W2041285232 cites W2088145115 @default.
• W2041285232 cites W2088532104 @default.
• W2041285232 cites W2091960586 @default.
• W2041285232 cites W2096587435 @default.
• W2041285232 cites W2098347923 @default.
• W2041285232 cites W2105250995 @default.
• W2041285232 cites W2108504869 @default.
• W2041285232 cites W2122811894 @default.
• W2041285232 cites W2125442778 @default.
• W2041285232 cites W2139842973 @default.
• W2041285232 cites W2140281675 @default.
• W2041285232 cites W2141957564 @default.
• W2041285232 cites W2148875180 @default.
• W2041285232 cites W2151617426 @default.
• W2041285232 cites W2152510677 @default.
• W2041285232 cites W2153553951 @default.
• W2041285232 cites W2156121263 @default.
• W2041285232 cites W2170810459 @default.
• W2041285232 cites W2312388685 @default.
• W2041285232 cites W2314840520 @default.
• W2041285232 cites W2333187183 @default.
• W2041285232 cites W2407071470 @default.
• W2041285232 cites W2516678716 @default.
• W2041285232 cites W2615684303 @default.
• W2041285232 cites W4230300241 @default.
• W2041285232 cites W4236618345 @default.
• W2041285232 cites W4240466289 @default.
• W2041285232 cites W4244923976 @default.
• W2041285232 cites W79218704 @default.
• W2041285232 doi "https://doi.org/10.1053/j.arrt.2004.02.001" @default.
• W2041285232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15216486" @default.
• W2041285232 hasPublicationYear "2004" @default.
• W2041285232 type Work @default.
• W2041285232 sameAs 2041285232 @default.
• W2041285232 citedByCount "13" @default.
• W2041285232 countsByYear W20412852322013 @default.
• W2041285232 countsByYear W20412852322014 @default.
• W2041285232 countsByYear W20412852322017 @default.
• W2041285232 countsByYear W20412852322018 @default.
• W2041285232 countsByYear W20412852322019 @default.
• W2041285232 countsByYear W20412852322020 @default.
• W2041285232 countsByYear W20412852322021 @default.
• W2041285232 countsByYear W20412852322023 @default.

• next